CATALENT FDA Approval ANDA 213105

ANDA 213105

CATALENT

FDA Drug Application

Application #213105

Application Sponsors

ANDA 213105CATALENT

Marketing Status

Over-the-counter001

Application Products

001CAPSULE;ORAL10MG0CETIRIZINE HYDROCHLORIDE ALLERGYCETIRIZINE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2020-09-21STANDARD

Submissions Property Types

ORIG1Null7

CDER Filings

CATALENT
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 213105
            [companyName] => CATALENT
            [docInserts] => ["",""]
            [products] => [{"drugName":"CETIRIZINE HYDROCHLORIDE ALLERGY","activeIngredients":"CETIRIZINE HYDROCHLORIDE","strength":"10MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Over-the-counter","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"09\/21\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-09-21
        )

)

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.